Detalhe da pesquisa
1.
Characterization of the immune environment in pregnancy-associated breast cancer.
Future Oncol
; 19(15): 1073-1089, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37376974
2.
Mismatch repair-deficient hormone receptor-positive breast cancers: Biology and pathological characterization.
Cancer Cell Int
; 21(1): 266, 2021 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34001143
3.
Combined analysis of PTEN, HER2, and hormone receptors status: remodeling breast cancer risk profiling.
BMC Cancer
; 21(1): 1152, 2021 Oct 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34706703
4.
ctDNA analysis in the personalized clinical management of gastroesophageal adenocarcinoma: turning hope into reality.
Future Oncol
; 17(33): 4607-4618, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34406032
5.
PTEN Expression as a Complementary Biomarker for Mismatch Repair Testing in Breast Cancer.
Int J Mol Sci
; 21(4)2020 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32098071
6.
Determination of Mismatch Repair Status in Human Cancer and Its Clinical Significance: Does One Size Fit All?
Adv Anat Pathol
; 26(4): 270-279, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-30932972
7.
Letter to the editor regarding the article "pregnancy-associated breast cancer: a multicenter study comparing clinicopathological factors, diagnosis, and treatment outcomes with non-pregnant patients".
Breast Cancer Res Treat
; 199(3): 587-588, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37074482
8.
Trop-2 as an Actionable Biomarker in Breast Cancer.
Curr Genomics
; 24(3): 129-131, 2023 Nov 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38178982
9.
Standardized pathology report for HER2 testing in compliance with 2023 ASCO/CAP updates and 2023 ESMO consensus statements on HER2-low breast cancer.
Virchows Arch
; 484(1): 3-14, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37770765
10.
Early Breast Cancer Risk Assessment: Integrating Histopathology with Artificial Intelligence.
Cancers (Basel)
; 16(11)2024 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38893102
11.
PD-L1 testing in metastatic triple-negative breast cancer: Interobserver and interplatform reproducibility of CE-IVD assays for CPS and IC scores.
Hum Pathol
; 144: 22-27, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38278450
12.
CDH1 Genotype Exploration in Women With Hereditary Lobular Breast Cancer Phenotype.
JAMA Netw Open
; 7(4): e247862, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38652475
13.
Malignancies in Patients with Celiac Disease: Diagnostic Challenges and Molecular Advances.
Genes (Basel)
; 14(2)2023 01 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-36833303
14.
Immune plasticity in pregnancy-associated breast cancer tumorigenesis.
Eur J Cancer Prev
; 32(4): 364-369, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37038998
15.
Immune Biomarkers in Triple-Negative Breast Cancer: Improving the Predictivity of Current Testing Methods.
J Pers Med
; 13(7)2023 Jul 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37511789
16.
Pathological identification of HER2-low breast cancer: Tips, tricks, and troubleshooting for the optimal test.
Front Mol Biosci
; 10: 1176309, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37077201
17.
Computational pathology to improve biomarker testing in breast cancer: how close are we?
Eur J Cancer Prev
; 32(5): 460-467, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37038997
18.
Breast Cancer with Brain Metastasis: Molecular Insights and Clinical Management.
Genes (Basel)
; 14(6)2023 05 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37372340
19.
The molecular landscape of breast mucoepidermoid carcinoma.
Cancer Med
; 12(9): 10725-10737, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36916425
20.
Clinicopathological features and survival outcomes of luminal-like breast tumors with estrogen receptor loss at metastatic recurrence: A case-control study.
Eur J Cancer
; 195: 113397, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37890353